Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in Adults

Clinical trial NCT07002060 · COMPLETED

Trial details

NCT number: NCT07002060
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Yellow Fever Immunization

Start date: 2025-05-22
Primary completion: 2026-01-20
Enrollment: 640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.